These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 31475738)

  • 1. Cyclin F-dependent degradation of E2F7 is critical for DNA repair and G2-phase progression.
    Yuan R; Liu Q; Segeren HA; Yuniati L; Guardavaccaro D; Lebbink RJ; Westendorp B; de Bruin A
    EMBO J; 2019 Oct; 38(20):e101430. PubMed ID: 31475738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feedback regulation between atypical E2Fs and APC/CCdh1 coordinates cell cycle progression.
    Boekhout M; Yuan R; Wondergem AP; Segeren HA; van Liere EA; Awol N; Jansen I; Wolthuis RM; de Bruin A; Westendorp B
    EMBO Rep; 2016 Mar; 17(3):414-27. PubMed ID: 26882548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complex Cartography: Regulation of E2F Transcription Factors by Cyclin F and Ubiquitin.
    Emanuele MJ; Enrico TP; Mouery RD; Wasserman D; Nachum S; Tzur A
    Trends Cell Biol; 2020 Aug; 30(8):640-652. PubMed ID: 32513610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclin F Controls Cell-Cycle Transcriptional Outputs by Directing the Degradation of the Three Activator E2Fs.
    Clijsters L; Hoencamp C; Calis JJA; Marzio A; Handgraaf SM; Cuitino MC; Rosenberg BR; Leone G; Pagano M
    Mol Cell; 2019 Jun; 74(6):1264-1277.e7. PubMed ID: 31130363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA-damage response control of E2F7 and E2F8.
    Zalmas LP; Zhao X; Graham AL; Fisher R; Reilly C; Coutts AS; La Thangue NB
    EMBO Rep; 2008 Mar; 9(3):252-9. PubMed ID: 18202719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell cycle oscillators underlying orderly proteolysis of E2F8.
    Wasserman D; Nachum S; Cohen M; Enrico TP; Noach-Hirsh M; Parasol J; Zomer-Polak S; Auerbach N; Sheinberger-Chorni E; Nevenzal H; Levi-Dadon N; Wang X; Lahmi R; Michaely E; Gerber D; Emanuele MJ; Tzur A
    Mol Biol Cell; 2020 Apr; 31(8):725-740. PubMed ID: 31995441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic functions of E2F7 and E2F8 are critical to suppress stress-induced skin cancer.
    Thurlings I; Martínez-López LM; Westendorp B; Zijp M; Kuiper R; Tooten P; Kent LN; Leone G; Vos HJ; Burgering B; de Bruin A
    Oncogene; 2017 Feb; 36(6):829-839. PubMed ID: 27452520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chk1 and 14-3-3 proteins inhibit atypical E2Fs to prevent a permanent cell cycle arrest.
    Yuan R; Vos HR; van Es RM; Chen J; Burgering BM; Westendorp B; de Bruin A
    EMBO J; 2018 Mar; 37(5):. PubMed ID: 29363506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. E2F7 represses a network of oscillating cell cycle genes to control S-phase progression.
    Westendorp B; Mokry M; Groot Koerkamp MJ; Holstege FC; Cuppen E; de Bruin A
    Nucleic Acids Res; 2012 Apr; 40(8):3511-23. PubMed ID: 22180533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. E2F1 proteolysis via SCF-cyclin F underlies synthetic lethality between cyclin F loss and Chk1 inhibition.
    Burdova K; Yang H; Faedda R; Hume S; Chauhan J; Ebner D; Kessler BM; Vendrell I; Drewry DH; Wells CI; Hatch SB; Dianov GL; Buffa FM; D'Angiolella V
    EMBO J; 2019 Oct; 38(20):e101443. PubMed ID: 31424118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. E2F7 Is a Potent Inhibitor of Liver Tumor Growth in Adult Mice.
    Moreno E; Toussaint MJM; van Essen SC; Bongiovanni L; van Liere EA; Koster MH; Yuan R; van Deursen JM; Westendorp B; de Bruin A
    Hepatology; 2021 Jan; 73(1):303-317. PubMed ID: 32259305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SCF(Cyclin F) controls centrosome homeostasis and mitotic fidelity through CP110 degradation.
    D'Angiolella V; Donato V; Vijayakumar S; Saraf A; Florens L; Washburn MP; Dynlacht B; Pagano M
    Nature; 2010 Jul; 466(7302):138-42. PubMed ID: 20596027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of E2F7 transcription factor with E2F1 and C-terminal-binding protein (CtBP) provides a mechanism for E2F7-dependent transcription repression.
    Liu B; Shats I; Angus SP; Gatza ML; Nevins JR
    J Biol Chem; 2013 Aug; 288(34):24581-9. PubMed ID: 23853115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical E2Fs inhibit tumor angiogenesis.
    Weijts BGMW; Westendorp B; Hien BT; Martínez-López LM; Zijp M; Thurlings I; Thomas RE; Schulte-Merker S; Bakker WJ; de Bruin A
    Oncogene; 2018 Jan; 37(2):271-276. PubMed ID: 28925392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclin F-Mediated Degradation of SLBP Limits H2A.X Accumulation and Apoptosis upon Genotoxic Stress in G2.
    Dankert JF; Rona G; Clijsters L; Geter P; Skaar JR; Bermudez-Hernandez K; Sassani E; Fenyö D; Ueberheide B; Schneider R; Pagano M
    Mol Cell; 2016 Nov; 64(3):507-519. PubMed ID: 27773672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. E2F7, a novel target, is up-regulated by p53 and mediates DNA damage-dependent transcriptional repression.
    Carvajal LA; Hamard PJ; Tonnessen C; Manfredi JJ
    Genes Dev; 2012 Jul; 26(14):1533-45. PubMed ID: 22802528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclin F/FBXO1 Interacts with HIV-1 Viral Infectivity Factor (Vif) and Restricts Progeny Virion Infectivity by Ubiquitination and Proteasomal Degradation of Vif Protein through SCF
    Augustine T; Chaudhary P; Gupta K; Islam S; Ghosh P; Santra MK; Mitra D
    J Biol Chem; 2017 Mar; 292(13):5349-5363. PubMed ID: 28184007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E2f8 mediates tumor suppression in postnatal liver development.
    Kent LN; Rakijas JB; Pandit SK; Westendorp B; Chen HZ; Huntington JT; Tang X; Bae S; Srivastava A; Senapati S; Koivisto C; Martin CK; Cuitino MC; Perez M; Clouse JM; Chokshi V; Shinde N; Kladney R; Sun D; Perez-Castro A; Matondo RB; Nantasanti S; Mokry M; Huang K; Machiraju R; Fernandez S; Rosol TJ; Coppola V; Pohar KS; Pipas JM; Schmidt CR; de Bruin A; Leone G
    J Clin Invest; 2016 Aug; 126(8):2955-69. PubMed ID: 27454291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclin F is degraded during G2-M by mechanisms fundamentally different from other cyclins.
    Fung TK; Siu WY; Yam CH; Lau A; Poon RY
    J Biol Chem; 2002 Sep; 277(38):35140-9. PubMed ID: 12122006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of E2F8, a novel E2F-like cell-cycle regulated repressor of E2F-activated transcription.
    Christensen J; Cloos P; Toftegaard U; Klinkenberg D; Bracken AP; Trinh E; Heeran M; Di Stefano L; Helin K
    Nucleic Acids Res; 2005; 33(17):5458-70. PubMed ID: 16179649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.